BiomX Inc. Quarterly Operating Income (Loss) in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BiomX Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q2 2024.
  • BiomX Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$9.73M, a 60.1% decline year-over-year.
  • BiomX Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$29.6M, a 21.3% decline year-over-year.
  • BiomX Inc. annual Operating Income (Loss) for 2023 was -$25.3M, a 6.87% increase from 2022.
  • BiomX Inc. annual Operating Income (Loss) for 2022 was -$27.2M, a 23.2% increase from 2021.
  • BiomX Inc. annual Operating Income (Loss) for 2021 was -$35.5M, a 17.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$29.6M -$9.73M -$3.65M -60.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$25.9M -$6.79M -$577K -9.29% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$25.3M -$5.27M +$288K +5.18% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-04
Q3 2023 -$25.6M -$7.8M -$1.25M -19% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$24.4M -$6.07M +$1.25M +17.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$25.6M -$6.21M +$1.58M +20.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$27.2M -$5.56M +$4.23M +43.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-04
Q3 2022 -$31.4M -$6.55M +$3.28M +33.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$34.7M -$7.32M -$22K -0.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$34.7M -$7.79M +$756K +8.85% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$35.5M -$9.79M -$717K -7.91% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$34.7M -$9.83M -$1M -11.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$33.7M -$7.3M -$908K -14.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$32.8M -$8.54M -$2.58M -43.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$30.3M -$9.07M +$693K +7.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$31M -$8.83M -$4.18M -89.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$26.8M -$6.39M -$2.33M -57.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$24.4M -$5.97M -$2.24M -60.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$22.2M -$9.76M -$9.75M -61722% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$12.5M -$4.66M -$4.65M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$7.81M -$4.07M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$3.72M -$3.72M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$15.8K Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-06
Q3 2018 -$650* Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-16
Q1 2018 -$1K* Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.